http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 27 Aug 2026 16:21:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+25++Filed+by%3A+FOSTER+JAMES+C/26990332.html si-local-file:///var/storage/secattach/20260827/26990332.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+25++Filed+by%3A+FOSTER+JAMES+C/26990332.html Thu, 27 Aug 2026 16:21:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+25++Filed+by%3A+FOSTER+JAMES+C/26990332.html si-local-file:///var/storage/secattach/20260827/26990332.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+25++Filed+by%3A+FOSTER+JAMES+C/26990332.html Thu, 27 Aug 2026 16:21:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+FOSTER+JAMES+C/26974769.html si-local-file:///var/storage/secattach/20260825/26974769.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+FOSTER+JAMES+C/26974769.html Tue, 25 Aug 2026 16:11:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+FOSTER+JAMES+C/26974769.html si-local-file:///var/storage/secattach/20260825/26974769.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+FOSTER+JAMES+C/26974769.html Tue, 25 Aug 2026 16:11:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Girshick+Birgit/26956699.html si-local-file:///var/storage/secattach/20260820/26956699.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Girshick+Birgit/26956699.html Thu, 20 Aug 2026 16:37:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Girshick+Birgit/26956699.html si-local-file:///var/storage/secattach/20260820/26956699.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Girshick+Birgit/26956699.html Thu, 20 Aug 2026 16:37:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Parisotto+Shannon+M/26956645.html si-local-file:///var/storage/secattach/20260820/26956645.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Parisotto+Shannon+M/26956645.html Thu, 20 Aug 2026 16:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Parisotto+Shannon+M/26956645.html si-local-file:///var/storage/secattach/20260820/26956645.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+19++Filed+by%3A+Parisotto+Shannon+M/26956645.html Thu, 20 Aug 2026 16:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+18++Filed+by%3A+Andrews+Nancy+C/26956599.html si-local-file:///var/storage/secattach/20260820/26956599.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+18++Filed+by%3A+Andrews+Nancy+C/26956599.html Thu, 20 Aug 2026 16:31:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+18++Filed+by%3A+Andrews+Nancy+C/26956599.html si-local-file:///var/storage/secattach/20260820/26956599.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+18++Filed+by%3A+Andrews+Nancy+C/26956599.html Thu, 20 Aug 2026 16:31:00 -0400 CRL O.00066481 http://www.streetinsider.com/Corporate+News/Charles+River+and+Medigen+to+use+NGS+for+enterovirus+vaccine+work/26953264.html <p>Charles River Laboratories International (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) have entered a collaboration to characterize and validate the virus seed bank for MVC's next-generation multivalent enterovirus vaccine, according to a press release from Charles River.</p><p>Under the agreement, Charles River will apply its Next-Generation Sequencing (NGS) and biologics testing platforms to support Chemistry, Manufacturing, and Controls (CMC) activities for the vaccine program. The companies also plan to conduct IND-enabling non-clinical studies and generate data to support Investigational New Drug (IND) applications for future global clinical development.</p><p>MVC's existing ENVACGEN® Enterovirus 71 Vaccine has received regulatory approval in Taiwan and http://www.streetinsider.com/Corporate+News/Charles+River+and+Medigen+to+use+NGS+for+enterovirus+vaccine+work/26953264.html Thu, 20 Aug 2026 08:03:37 -0400 CRL http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html <p class="bwalignc"> <i>Collaboration leverages NGS technologies to accelerate high-quality vaccine development, support global regulatory readiness, and help reduce animal testing</i> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) collaborate<b> </b>on the characterization and validation of the virus seed bank for MVC's next-generation multivalent enterovirus vaccine. Charles River will leverage its advanced analytical platforms, including Next-Generation Sequencing (NGS), to support critical steps of Chemistry, Manufacturing, and Controls (CMC) activities for MVC’s next-generation multivalent enterovirus vaccine. The collaboration reflects both companies' shared commitment to high-quality development, scientific rigor, and accelerated alignment with global http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html Thu, 20 Aug 2026 08:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html <p class="bwalignc"> <i>Collaboration leverages NGS technologies to accelerate high-quality vaccine development, support global regulatory readiness, and help reduce animal testing</i> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) collaborate<b> </b>on the characterization and validation of the virus seed bank for MVC's next-generation multivalent enterovirus vaccine. Charles River will leverage its advanced analytical platforms, including Next-Generation Sequencing (NGS), to support critical steps of Chemistry, Manufacturing, and Controls (CMC) activities for MVC’s next-generation multivalent enterovirus vaccine. The collaboration reflects both companies' shared commitment to high-quality development, scientific rigor, and accelerated alignment with global http://www.streetinsider.com/Press+Releases/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html Thu, 20 Aug 2026 08:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html <p class="bwalignc"> <i>Collaboration leverages NGS technologies to accelerate high-quality vaccine development, support global regulatory readiness, and help reduce animal testing</i> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) collaborate<b> </b>on the characterization and validation of the virus seed bank for MVC's next-generation multivalent enterovirus vaccine. Charles River will leverage its advanced analytical platforms, including Next-Generation Sequencing (NGS), to support critical steps of Chemistry, Manufacturing, and Controls (CMC) activities for MVC’s next-generation multivalent enterovirus vaccine. The collaboration reflects both companies' shared commitment to high-quality development, scientific rigor, and accelerated alignment with global http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html Thu, 20 Aug 2026 08:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html <p class="bwalignc"> <i>Collaboration leverages NGS technologies to accelerate high-quality vaccine development, support global regulatory readiness, and help reduce animal testing</i> </p> <p> WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) and Medigen Vaccine Biologics Corp. (MVC) collaborate<b> </b>on the characterization and validation of the virus seed bank for MVC's next-generation multivalent enterovirus vaccine. Charles River will leverage its advanced analytical platforms, including Next-Generation Sequencing (NGS), to support critical steps of Chemistry, Manufacturing, and Controls (CMC) activities for MVC’s next-generation multivalent enterovirus vaccine. The collaboration reflects both companies' shared commitment to high-quality development, scientific rigor, and accelerated alignment with global http://www.streetinsider.com/Business+Wire/Charles+River+Laboratories+and+Medigen+Vaccine+Biologics+Corp+Collaborate+to+Advance+New+Vaccine+Development+Programs+Through+Next+Generation+Sequencing/26953097.html Thu, 20 Aug 2026 08:00:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Parisotto+Shannon+M/26950270.html si-local-file:///var/storage/secattach/20260819/26950270.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Parisotto+Shannon+M/26950270.html Wed, 19 Aug 2026 16:16:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Parisotto+Shannon+M/26950270.html si-local-file:///var/storage/secattach/20260819/26950270.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Parisotto+Shannon+M/26950270.html Wed, 19 Aug 2026 16:16:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Andrews+Nancy+C/26942591.html si-local-file:///var/storage/secattach/20260818/26942591.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Andrews+Nancy+C/26942591.html Tue, 18 Aug 2026 11:06:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Andrews+Nancy+C/26942591.html si-local-file:///var/storage/secattach/20260818/26942591.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Andrews+Nancy+C/26942591.html Tue, 18 Aug 2026 11:06:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Girshick+Birgit/26922063.html si-local-file:///var/storage/secattach/20260813/26922063.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Girshick+Birgit/26922063.html Thu, 13 Aug 2026 16:38:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Girshick+Birgit/26922063.html si-local-file:///var/storage/secattach/20260813/26922063.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Girshick+Birgit/26922063.html Thu, 13 Aug 2026 16:38:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Parisotto+Shannon+M/26921998.html si-local-file:///var/storage/secattach/20260813/26921998.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Parisotto+Shannon+M/26921998.html Thu, 13 Aug 2026 16:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Parisotto+Shannon+M/26921998.html si-local-file:///var/storage/secattach/20260813/26921998.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Aug+11++Filed+by%3A+Parisotto+Shannon+M/26921998.html Thu, 13 Aug 2026 16:34:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Invesco+Ltd./26919842.html si-local-file:///var/storage/secattach/20260813/26919842.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Invesco+Ltd./26919842.html Thu, 13 Aug 2026 14:19:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Invesco+Ltd./26919842.html si-local-file:///var/storage/secattach/20260813/26919842.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++CHARLES+RIVER+LABORATORI+++++++++++++++Filed+by%3A+Invesco+Ltd./26919842.html Thu, 13 Aug 2026 14:19:00 -0400 CRL O.00066481